Neuro-Adaptive Photobiomodulation Therapy System

Publication ID: 24-11857800_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Neuro-Adaptive Photobiomodulation Therapy System,” Published Technical Disclosure No. 24-11857800_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857800_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,800.

Summary of the Inventive Concept

A wearable photobiomodulation therapy system that integrates brain-computer interfaces, artificial intelligence, and machine learning algorithms to provide personalized, real-time treatment protocols for neurological disorders and other conditions.

Background and Problem Solved

The original patent application for photobiomodulation therapy garments demonstrated the potential for near-infrared light to treat various disorders. However, these early systems were limited by their fixed dosimetry and lack of real-time feedback. The new inventive concept addresses these limitations by incorporating advanced technologies to create a more sophisticated, adaptive, and effective treatment system.

Detailed Description of the Inventive Concept

The Neuro-Adaptive Photobiomodulation Therapy System consists of a wearable garment or device that incorporates multiple near-infrared light sources, sensors, and a brain-computer interface. The system utilizes artificial intelligence-driven algorithms to analyze real-time neural activity feedback and adjust near-infrared light dosimetry accordingly. This ensures optimal treatment efficacy and minimizes potential side effects. The system can also integrate machine learning algorithms to predict and adapt to individual user responses, further enhancing treatment outcomes. Additionally, the system can be configured to administer simultaneous, multi-wavelength near-infrared light therapy, where each wavelength is optimized for a specific biological effect.

Novelty and Inventive Step

The new inventive concept's integration of brain-computer interfaces, artificial intelligence, and machine learning algorithms represents a significant departure from the original patent's fixed dosimetry and lack of real-time feedback. The Neuro-Adaptive Photobiomodulation Therapy System's ability to adapt to individual user responses and provide personalized treatment protocols is a substantial improvement over existing photobiomodulation therapy systems.

Alternative Embodiments and Variations

Alternative embodiments of the Neuro-Adaptive Photobiomodulation Therapy System could include variations in the type and number of near-infrared light sources, sensors, and brain-computer interfaces used. Additionally, the system could be adapted for use in different treatment settings, such as clinical or home-based care, and could be integrated with other therapeutic modalities, such as electrical stimulation or cognitive training.

Potential Commercial Applications and Market

The Neuro-Adaptive Photobiomodulation Therapy System has significant commercial potential in the treatment of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and depression. The system could also be applied to other conditions, such as chronic pain, inflammation, and wound healing. The market for photobiomodulation therapy devices is expected to grow significantly in the coming years, driven by increasing awareness of the technology's potential benefits and the need for more effective treatment options.

Field of Art

Biomedical engineering, specifically photobiomodulation therapy devices and neural interface technologies, requiring advanced knowledge of light-based medical treatments, neurotechnology, and wearable medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in near-infrared light therapy, neural interfaces, and adaptive medical technologies, holding advanced degrees in bioengineering or related fields with experience in medical device development

Obviousness Rationale

A person having ordinary skill in the art would recognize that integrating brain-computer interfaces and artificial intelligence with existing photobiomodulation therapy technologies represents a predictable extension of known medical device design principles. The source patent's foundational photobiomodulation garment provides a clear technological framework that a skilled practitioner would naturally seek to enhance through advanced sensing and adaptive technologies. The PTD's variations represent logical technological progressions that combine well-understood techniques in neural monitoring, machine learning, and personalized medical treatment.

Obvious Combinations & Variations

Source Patent Element
Photobiomodulation therapy headband with near-infrared light sources
PTD Variation
Adding brain-computer interface sensors to dynamically adjust light dosimetry
Obviousness Reasoning
Integrating real-time neural feedback is a predictable enhancement for medical monitoring devices, representing a known technique for improving treatment precision
Source Patent Element
Fixed irradiance range of 50-300 mW/cm2 for near-infrared light
PTD Variation
Multi-wavelength light therapy with AI-optimized dosimetry
Obviousness Reasoning
Expanding treatment parameters through intelligent control represents a standard design optimization approach in medical device engineering
Source Patent Element
Wearable garment configured for photobiomodulation therapy
PTD Variation
Cloud-connected IoT device with machine learning treatment adaptation
Obviousness Reasoning
Incorporating remote monitoring and adaptive algorithms is a foreseeable technological progression for medical wearable devices
Source Patent Element
Near-infrared light emitting diode light sources
PTD Variation
Simultaneous multi-wavelength light sources with targeted biological effects
Obviousness Reasoning
Expanding light source configurations to achieve specific therapeutic outcomes is a standard approach in biomedical device design
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857800 and the disclosed technological variations, a person having ordinary skill in the art would find the claimed innovations of the Neuro-Adaptive Photobiomodulation Therapy System obvious and lacking inventive step. The combination of known photobiomodulation techniques with emerging neural interface and machine learning technologies represents a predictable extension of existing medical device design principles, thereby rendering such claims obvious under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,800
TitlePhotobiomodulation therapy garment, methods and uses
Assignee(s)Niraxx, Inc.